Xian Shuang Liu Selected Research

Atorvastatin (Lipitor)

11/2007	The PI3K/Akt pathway mediates the neuroprotective effect of atorvastatin in extending thrombolytic therapy after embolic stroke in the rat.
6/2006	Atorvastatin downregulates tissue plasminogen activator-aggravated genes mediating coagulation and vascular permeability in single cerebral endothelial cells captured by laser microdissection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xian Shuang Liu Research Topics

Disease

13	Stroke (Strokes) 01/2020 - 06/2006
5	Peripheral Nervous System Diseases (PNS Diseases) 01/2021 - 12/2017
4	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2017 - 03/2007
3	Brain Ischemia (Cerebral Ischemia) 01/2020 - 01/2011
3	Infarction (Infarctions) 01/2017 - 08/2012
2	Embolic Stroke 11/2007 - 06/2006
1	Diabetes Complications 01/2021
1	Inflammation (Inflammations) 01/2021
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Body Weight (Weight, Body) 01/2018
1	Hyperglycemia 12/2017
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 11/2014
1	Cerebral Infarction 08/2013
1	Ischemia 08/2013
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2011
1	Thrombosis (Thrombus) 06/2006

Drug/Important Bio-Agent (IBA)

8	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2011
4	NAD (NADH)IBA 01/2021 - 12/2017
2	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2017
2	Therapeutic UsesIBA 12/2017 - 01/2011
2	LigandsIBA 08/2008 - 08/2007
2	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2007 - 06/2006
2	Atorvastatin (Lipitor)FDA Link 11/2007 - 06/2006
1	Long Noncoding RNAIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	ThymosinIBA 01/2019
1	CholesterolIBA 01/2018
1	Blood Glucose (Blood Sugar)IBA 01/2018
1	Glycogen Synthase KinasesIBA 01/2017
1	TensinsIBA 01/2017
1	Liposomes (Liposome)IBA 01/2017
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	Sirolimus (Rapamycin)FDA Link 01/2017
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2017
1	Histone Deacetylases (Histone Deacetylase)IBA 11/2014
1	Histones (Histone)IBA 11/2014
1	Bromodeoxyuridine (BrdU)IBA 11/2014
1	Glycogen Synthase (Synthase I)IBA 08/2012
1	Myelin Basic ProteinIBA 08/2012
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 08/2012
1	CollagenIBA 01/2011
1	Angiopoietin-2IBA 08/2009
1	Chemokine ReceptorsIBA 08/2008
1	Neuroprotective AgentsIBA 11/2007
1	Phosphotransferases (Kinase)IBA 11/2007
1	ChemokinesIBA 08/2007
1	Biological ProductsIBA 03/2007
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 03/2007
1	Matrix Metalloproteinases (MMPs)IBA 06/2006
1	Thromboplastin (Tissue Factor)IBA 06/2006
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2006
1	PAR-1 ReceptorIBA 06/2006
1	Messenger RNA (mRNA)IBA 06/2006

Therapy/Procedure

1	Thrombolytic Therapy 11/2007
1	Therapeutics 11/2007
1	Lasers (Laser) 03/2007